Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5568282

CC[C@H](N)C(=O)N1c2ccc(Cl)c(Cl)c2C[C@@H]1C(=O)NCC(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
F2 P00734 7/20 0.33
F10 P00742 7/20 0.33
PRSS1 P07477 7/20 0.33
PRSS2 P07478 7/20 0.33
PRSS3 P35030 7/20 0.33
F12 P00748 6/20 0.33
F7 P08709 6/20 0.33
XIAP P98170 3/20 0.33
F9 P00740 2/20 0.32
CXCR3 P49682 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5568354 1.00 KDM4E (0.45) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL5568302 0.96 KDM4E (0.48) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL7659015 0.96 KDM4E (0.48) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
Trifluoroacetic Acid SCHEMBL7650915 0.89 KDM4E (0.59) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
Trifluoroacetic Acid SCHEMBL5569571 0.85 KDM4E (0.34) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
Trifluoroacetic Acid SCHEMBL5569402 0.84 KDM4E (0.48) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
2,2,2-Trifluoroethanaminium SCHEMBL8252511 0.82 KDM4E (0.38) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL7657397 0.82 KDM4E (0.67) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL5568286 0.81 CTSK (0.34) KDM4EALDH1A1CXCR3
SCHEMBL5568891 0.80 KDM4E (0.51) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1042288-B1 TRIPEPTIDYL PEPTIDASE INHIBITORS INST NAT SANTE RECH MED (FR) 2007-11-07 EP claimed
US-6335360-B1 INDOLINE-2-CARBOXYLIC AMIDE DERIVATIVES; OBESITY, EATING AND PSYCHOLOGICAL DISORDERS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2002-01-01 US claimed
EP-1042288-A1 TRIPEPTIDYL PEPTIDASE INHIBITORS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2000-10-11 EP claimed
WO-1999033801-A1 TRIPEPTIDYL PEPTIDASE INHIBITORS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1999-07-08 WO claimed
EP-1042288-B1 TRIPEPTIDYL PEPTIDASE INHIBITORS INST NAT SANTE RECH MED (FR) 2007-11-07 EP disclosed
US-6335360-B1 INDOLINE-2-CARBOXYLIC AMIDE DERIVATIVES; OBESITY, EATING AND PSYCHOLOGICAL DISORDERS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2002-01-01 US disclosed
EP-1042288-A1 TRIPEPTIDYL PEPTIDASE INHIBITORS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2000-10-11 EP disclosed
WO-1999033801-A1 TRIPEPTIDYL PEPTIDASE INHIBITORS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 1999-07-08 WO disclosed